New faculty who joined VP&S in April and June include an emergency medicine doctor and a radiologist who has helped translate state-of-the-art imaging techniques.
New faculty who joined VP&S in February and March include the chair of the Department of Radiology and the vice chair for basic research in the Department of Pediatrics.
New faculty who joined VP&S in recent months include a specialist in managing infections in immunocompromised patients and a researcher of precision cellular immunotherapies for autoimmunity.
Researchers have identified a biomarker that predicts which stage II colon cancer patients may benefit from adjuvant chemotherapy to prevent a disease recurrence.
A new study has revealed that cholesterol-lowering statins may help reverse the mechanisms that increase the risk of heart disease in people with sleep apnea.
Increased connectivity in the brain's default mode network is a potential precursor, or biomarker, indicating a risk of developing major depressive disorder.
P&S researcher Wendy Chung and colleagues find genetic mutations that explain why many children with congenital heart disease also have neurodevelopmental disorders.
Kevin Roth, MD, PhD, has been named chair of the P&S Department of Pathology & Cell Biology and pathologist-in-chief at NewYork-Presbyterian/Columbia University Medical Center.